Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-15 @ 4:24 PM
Study NCT ID:
NCT00600366
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2008-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2005-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-14
First Submit QC Date:
None
Study First Post Date:
2008-01-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-05
Last Update Post Date:
2017-01-06
Last Update Post Date Type:
ESTIMATED